drugset / Trial / NCT00196755
Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to demonstrate that sevelamer hydrochloride is non-inferior to calcium acetate for the treatment of hyperphosphataemia in patients receiving peritoneal dialysis.
Timeline
- Start
- 2004-12
- Primary completion
- 2006-03
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sevelamer | Other / unclassified | — | — |
| Comparator | calcium acetate | Other / unclassified | — | — |